This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Nanotech Players' Low-Risk Profile

Next time a conversation with a fellow investor starts to flag, here are two sure ways to jump-start it: Change the subject to the perils of nanotechnology, or change it to social and environmental responsibility.

And if you really want to get things hopping, start talking about both at once.

That's just what Heather Langsner has done. A senior analyst at Innovest Strategic Value Advisors, a New York company that describes itself as "an environmental investment research advisory firm," Langsner not only compiled a nanotech index for value investors, she backed it up with a report that assesses, in part, "the perception risk that may be associated with the environmental, health and safety profile of nanotechnology."

Never mind that the world of nano, still more science than technology, is a bit young to be a preoccupation of value investors. Or that the debate over environmental and health hazards from nanotech applications, while raging in Europe, is much more muted in the U.S. Or that the field of social responsibility is still reeling from The Economist's 11,000-word jeremiad in January, which dismissed it as "morally dubious" and "a license to obfuscate."

Innovest's nanotech report offers serious food for thought for nanotech investors. First off, Langsner scores points for writing a 124-page report without once reaching for the phrase "grey goo" -- the world-smothering result of self-replicating nanorobots run amok (kind of like blogs, only with molecules instead of opinions).

More importantly, Innovest's report analyzes a more immediate risk than grey goo: How likely are emerging technologies to cause consumers to freak out as some did over the perceived health threats of genetically modified organisms, and further, how smart are companies in heading off that threat?

After all, profiting from emerging technologies depends as much on exploiting their promise as avoiding their pitfalls -- how do you get genetically modified seeds to help agriculture without harming nature? Or run a nuclear plant without nuclear meltdowns? Or conduct data mining without privacy invasions? Companies diligent in addressing such questions have done well, while the cavalier have suffered.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
FEIC $79.91 1.16%
GE $26.11 0.46%
MON $121.30 0.72%
VECO $31.00 1.67%
AAPL $129.09 0.49%

Markets

DOW 18,288.63 +155.93 0.86%
S&P 500 2,117.39 +12.89 0.61%
NASDAQ 5,008.0960 +44.5690 0.90%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs